Literature DB >> 24064671

From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.

M A Ingersoll1, M L Albert.   

Abstract

The pathogenesis of urinary tract infection and mechanisms of the protective effect of Bacillus Calmette-Guerin (BCG) therapy for bladder cancer highlight the importance of studying the bladder as a unique mucosal surface. Innate responses to bacteria are reviewed, and although our collective knowledge remains incomplete, we discuss how adaptive immunity may be generated following bacterial challenge in the bladder microenvironment. Interestingly, the widely held belief that the bladder is sterile has been challenged recently, indicating the need for further study of the impact of commensal microorganisms on the immune response to uropathogen infection or intentional instillation of BCG. This review addresses the aspects of bladder biology that have been well explored and defines what still must be discovered about the immunobiology of this understudied organ.

Entities:  

Mesh:

Year:  2013        PMID: 24064671     DOI: 10.1038/mi.2013.72

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  34 in total

1.  Microbiome, a new dimension in cancer research.

Authors:  Antonio Galvao Neto; Azore-Dee Bradshaw; Zhiheng Pei
Journal:  Ann Transl Med       Date:  2015-09

Review 2.  Cancer and the microbiota.

Authors:  Wendy S Garrett
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

Review 3.  Pathogenesis of Proteus mirabilis Infection.

Authors:  Chelsie E Armbruster; Harry L T Mobley; Melanie M Pearson
Journal:  EcoSal Plus       Date:  2018-02

Review 4.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  [Candiduria! What now? : Therapy of urinary tract infections with Candida].

Authors:  H Hof
Journal:  Urologe A       Date:  2017-02       Impact factor: 0.639

Review 6.  Future directions in bladder cancer immunotherapy: towards adaptive immunity.

Authors:  Sean G Smith; David A Zaharoff
Journal:  Immunotherapy       Date:  2016-02-09       Impact factor: 4.196

7.  BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer.

Authors:  Aleksandar Obradovic; Alok Kumar Singh; Kara A Lombardo; James L Liu; Gregory Joice; Max Kates; William Bishai; David McConkey; Alcides Chaux; Marie-Lisa Eich; M Katayoon Rezaei; George J Netto; Charles G Drake; Phuoc Tran; Andres Matoso; Trinity J Bivalacqua
Journal:  J Pathol       Date:  2021-12-10       Impact factor: 7.996

Review 8.  The nature of immune responses to urinary tract infections.

Authors:  Soman N Abraham; Yuxuan Miao
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

9.  Effect of Preoperative Bacteriuria and Pyuria on Intravesical Recurrence in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.

Authors:  Hiroshi Fukushima; Masaki Kobayashi; Keizo Kawano; Shinji Morimoto
Journal:  In Vivo       Date:  2017 Nov-Dec       Impact factor: 2.155

Review 10.  Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions.

Authors:  Kuan-Wei Shih; Wei-Chieh Chen; Ching-Hsin Chang; Ting-En Tai; Jeng-Cheng Wu; Andy C Huang; Ming-Che Liu
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.